24/7 Customer Support

United States Clinical Laboratory Services Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

United States Clinical Laboratory Services market: By Test Type (Clinical Chemistry Testing, Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Genetic Testing and Drug of Abuse Testing): Applications (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services and Others): End User (Hospitals, Government Agencies, Physicians, Clinicals Labs, Pharmaceutical Companies and Others): Region—Industry Dynamics, Market Size, Opportunity and Forecast 2023–2030

  • Published Date: 06-Mar-2023  |   Format: pdfpowerpointexcel  |  Report ID: AA0323376  | Delivery: 2 to 4 Hours

REPORT SCOPE

Report AttributeDetails
Market Size Value in 2022US$ 93.0 Billion
Expected Revenue in 2030US$ 125.6 Billion
Historic Data2018-2021
Base Year2022
Forecast Period2023-2030
UnitValue (USD Bn)
CAGR4.2% (2023-2030)
Segments coveredBy Test Type, By Application, By End-User
Key Companies                                                                                                                             Qiagen Inc., Opko Health, Inc., Abbott Laboratories, Charles River Laboratories, Johnson & Johnson, Roche Laboratories, Pfizer Inc, Eli Lilly, Novartis Laboratories, Merck Inc., Astrazeneca, Arup Laboratories, Davita, Inc., Siemens Healthcare Limited, Viapath Group Llp, Almac Group, Neogenomics Laborateries, Eurofins Scientific, UNILABS, SYNLAB International GmbH, H.U. Groups Holdings, Inc., Sonic Healthcare, ACM Global Laboratories, Amedes Holding GmbH, BioReference Laboratories, Inc., Other Prominent Players
Customization ScopeGet your customized report as per your preference. Ask for customization

LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.

SPEAK TO AN ANALYST